Pre- and postoperative chemotherapy including Bevacizumab in potentially curable metastatic colorectal Cancer (mCRC). A multicenter, prospective Phase I/II academic trial.
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2520675
下载链接
链接失效反馈官方服务：
资源简介：
primary objective: Resectability (R0) rate after neoadjuvant XELOX+Avastin in potentially resectable mCRC
primary objective: Resectability (R0) rate after neoadjuvant Avastin in potentially resectable mCRCsecondary objectives: Feasibility with regards to GI bleeding and wound healing complications after surgery of liver metastases, general safety, ORR, RFS, OS
创建时间：
2006-11-15
